At least some of the DNA instability (insertions, deletions and translocations) observed in cancer is nonrandom and recurrent. However, it is not clear to what extent this reflects the selection of certain instabilities because of the growth advantage they confer, or whether there are specific regions of the genome that are predisposed to instability. Common fragile sites induced on chromosomes in vitro correspond to regions of DNA instability observed in human cancers in vivo (Richards, 2001) . It is not known whether damage at these sites is merely a consequence of the environmental stresses to which the cells have been subjected or whether the instability actually plays a causal role in determining cellular neoplastic transformation. The extent to which this fragile site-associated instability contributes to cancer is likely to depend upon the relationship between the fragile site and genes in the vicinity whose function is perturbed.
A clear precedent for an association between a common chromosomal fragile site and a cancer-related gene has been demonstrated for the most highly expressed common fragile site, FRA3B, and the FHIT gene that spans it (Pekarsky et al., 2002) . The product of the FHIT gene is reduced or absent in many human cancers and functional studies in a mouse knockout model have demonstrated that Fhit is able to act as a tumour suppressor in mice (Zanesi et al., 2001) . We have previously localized the minimum region required for the cytogenetic expression of the second most highly expressed common fragile site, FRA16D, and found that this region is subject to homozygous deletion in certain forms of cancer Finnis et al., 2005) . The FRA16D region sequence allowed the identification of a transcript (Fragile site FRA16D OxidoReductase -FOR) that spans the FRA16D fragile site . Transcripts from the alternatively spliced FOR gene encode proteins with common N-terminal WW domains and variable homology to the oxidoreductase family of proteins. The gene has therefore also been named WWOX (Bednarek et al., 2000) . WWOX is the most likely gene to convey any biological consequences of DNA instability at the FRA16D locus. The possible processes to which WWOX contributes may be evident from the roles and arrangement of its conserved domains in other proteins. WWOX is one of several proteins that contain a pair of WW domains separated by an approximately 10 amino-acid linker. In the yeast splicing factor Prp40, this arrangement leads to outward facing WW domains that bind to different proteins and bring them into juxtaposition (Wiesner et al., 2002) . This suggests that WWOX may also act as a bridge between different proteins. In addition to WW domains, WWOX contains all of the essential sequences for an oxidoreductase enzyme. Another oxidoreductase, NAD(P)H:quinone oxido-reductase 1 (NQO1), is known to be protective in response to increased reactive oxygen species that can result from ionizing radiation (Nioi and Hayes, 2004) . Thus, WWOX may also play a role in oxidative stress response following ionizing radiation. Importantly, the WWOX proteins from different species are distinct from other oxidoreductases, suggesting that WWOX performs a unique and highly conserved function.
WWOX has been identified and characterized by other approaches, also based on a proposed relationship between this gene and cancer. It was isolated as one of the genes induced in response to hyaluronidase treatment in mouse and shown to demonstrate both physical and functional interactions with p53 in vitro (Chang et al., 2001) . WWOX was also identified as a candidate tumour suppressor gene by virtue of its location within a region of loss of heterozygosity (LOH) observed in breast cancer (Bednarek et al., 2000) . Cancer-associated genes found in LOH regions are typically tumour suppressor genes, the LOH accounting for the loss of function of one allele, while point mutations or aberrant methylation usually inactivate the other. Some functional evidence has been produced in favour of the WWOX gene acting as a tumour suppressor (Bednarek et al., 2001; Paige et al., 2001) . However, the lack of mutations in the second allele in cancer cells and the sometimes elevated rather than diminished level of expression of the gene in cancer cells have led some to conclude that the WWOX gene does not encode a 'classical' tumour suppressor (Watanabe et al., 2003) . While the normal function of WWOX is currently unknown, its aberrant expression in a variety of cancer cell types has been extensively reported, also suggesting a likely association with cancer cell biology Paige et al., 2001; Yakicier et al., 2001; Driouch et al., 2002; Kuroki et al., 2002; Ishii et al., 2003; Yendamuri et al., 2003; Aqeilan et al., 2004a; Guler et al., 2004; Kuroki et al., 2004) .
Since its discovery, WWOX has been reported to interact with a growing set of functionally diverse proteins including p53 (Chang et al., 2001) , JNK1 (Chang et al., 2003) , Tau (Sze et al., 2004) , SIMPLE (Ludes-Meyers et al., 2004) , p73 (Aqeilan et al., 2004c) and AP-2g (Aqeilan et al., 2004b) . These in vitro associations have shed some light on the possible function(s) of WWOX, principally suggesting a role in apoptosis. However, the biological significance of these associations is not yet known. Therefore, despite the association between the WWOX gene and the DNA instability seen at the FRA16D fragile site in cancer, the normal function of the WWOX-encoded proteins and their possible contribution to cancer cell biology remain unclear. To address this, we have undertaken an analysis of the function of WWOX using the genetically amenable model organism Drosophila to identify the biological processes and pathways to which the WWOX proteins contribute.
Database searching identified CG7221 as the orthologue of WWOX in Drosophila. The protein product of CG7221 shares 49% identity with human WWOX. Phylogenetic analysis confirmed that DmWWOX clearly groups with WWOX proteins from other species onto a distinct branch of oxidoreductases (Figure 1a) . None of the most closely related oxidoreductases from either human or Drosophila locate within the WWOX orthologous branch. Having identified CG7221/ DmWWOX as the Drosophila orthologue of WWOX, we generated a null mutant in DmWWOX by homologous recombination (we have called this mutant DmWWOX 1 ). We performed 'ends-in' targeting essentially as described in Rong et al. (2002) . A 5 kb genomic region of DmWWOX was amplified from wild-type genomic DNA and site-directed mutagenesis was used to introduce mutations 24 bp downstream of the start codon. These mutations encode two premature stop codons, a þ 1 frame shift and a diagnostic SalI site ( Figure 1b ). In addition, an I-SceI site necessary for the targeting event was introduced into the third intron. This mutated fragment was cloned into the pTV 2 vector and transformed into wild-type flies to generate donor lines for gene targeting. A schematic of the targeting strategy and details of the methods used are described in the Supplementary information. Briefly, we screened 193 000 flies and obtained five insertion lines, four of which mapped to the second chromosome (the location of the endogenous DmWWOX gene). Following reduction, we screened the white-eyed progeny of multiple mosaic flies with allele-specific primers to identify those which had incorporated the desired mutations. Once we had generated homozygous stocks of these reduced lines, we used allele-specific primers to confirm that the DmWWOX 1 mutant flies no longer contained any wildtype sequences (Figure 1b) . A PCR product with the 9778/WT primer combination was observed only in the wild-type sample ( Figure 1c , lanes 1 and 3), while the 9778/MUT primer combination only produced a product in the DmWWOX 1 mutant sample ( Figure 1c , lanes 2 and 4). The 9778 primer lies outside of the region included in the genomic construct for targeting; thus, PCR products of the correct size obtained with 9778/MUT primer combination confirmed targeting to the correct genomic locus. The presence of the diagnostic SalI site in DmWWOX 1 mutant but not wild type was confirmed by digestion of the PCR product from 9778/339R ( Figure 1d , lanes 1-4). Finally, sequencing downstream of the start codon confirmed the presence of the premature termination codons, the þ 1 frame shift mutation and the SalI site ( Figure 1e ).
The absence of endogenous protein in these DmWWOX 1 mutants was confirmed by Western analysis using antibodies we generated against a C-terminal peptide (Figure 2a We were unable to detect the low level of endogenous DmWWOX expression above background in wholemount embryos. However, in embryos carrying engrailed-GAL4 and UAS-DmWWOX constructs (en> DmWWOX), strong alternating stripes of expression were seen along the length of the embryo (Figure 2c ). DmWWOX was clearly cytoplasmic within these stripes of expression (Figure 2e, g and i) . The same staining pattern was also observed when human WWOX Figure 1 Generation of a mutant in DmWWOX, the Drosophila orthologue of WWOX. (a) Phylogenetic analysis revealed that CG7221/DmWWOX groups with WWOX proteins from other species (top group) rather than the most closely related oxidoreductases from Drosophila, mouse or human (bottom group). The length of each pair of branches represents the distance between sequence pairs, while the scale at the bottom of the tree indicates the number of substitution events. Phylogenetic analysis was performed using 'MegAlign' from the Lasergene suite of programs from DNASTAR, Inc. (Madison, WI, USA). Accession numbers for FOR/WWOX sequences used in this analysis are H. sapiens (AAF82054), P. pygmaeus (CAH91445), M. musculus (NP_062519), R. norvegicus (XP_214696), G. gallus (XP_414161), D. rerio (NP_957207), F. rubripes (FRUP00000070477), C. intestinalis (AK115111.1), D. pseudoobscura (EAL33941), A. gambiae (XP_317022) and A. mellifera (XP_395282). (b) A schematic of the 5 kb genomic region of DmWWOX inserted into the pTV2 targeting vector. Mutations were introduced 24 bp downstream of the start codon. These mutations encode two premature stop codons, a þ 1 frame shift and a diagnostic SalI site in the first exon (triangle with asterisk), in addition to an I-SceI site in the third intron (triangle). DmWWOX exons are represented by the shaded boxes. The positions of primers used for PCR analyses are also shown. (c) PCR analysis using allele-specific primers revealed a 629 bp product in wild-type samples, with 9778/WT but not 9778/MUT (lanes 1 and 2) . Conversely, in DmWWOX 1 samples a 629 bp product was seen with 9778/MUT but not 9778/WT (lanes 3 and 4). (d) PCR products of the expected size (993 bp) were obtained from wild type and DmWWOX 1 using 9778/339R (lanes 1 and 2) . However, only the DmWWOX 1 product was digested with SalI to give 629 and 364 bp products (lanes 3 and 4). (e) Sequencing of PCR products confirmed the introduction of the premature stop codons, þ 1 frame shift and the diagnostic SalI site into the endogenous DmWWOX gene (hWWOX) was ectopically expressed in the same pattern (en>hWWOX) and stained with an antibody directed against the N-terminal region of hWWOX (Figure 2d , f, h and j). These observations are in agreement with the cytoplasmic staining of hWWOX observed when ectopically expressed in mammalian tissue culture cells but do not resolve the conflicting reports of subcellular localization of WWOX to the Golgi or mitochondria (Bednarek et al., 2001; Chang et al., 2001) .
Homozygous DmWWOX 1 mutant flies were viable and displayed no obvious phenotype. In addition, the overexpression of DmWWOX either ubiquitously using the daughterless promoter or in alternating stripes using the engrailed promoter resulted in no obvious phenotype. It has previously been reported that WWOX is an essential partner of p53 during TNF-mediated apoptosis A single band of ectopic DmWWOX staining at high power revealed the cytoplasmic localization of DmWWOX (green), which is complementary to the nuclear DNA stain (red) (d, f, h and j) Similar stripes of expression were observed in embryos ectopically expressing human WWOX (en>hWWOX), which was also cytoplasmically localized. For Western analysis, larvae and dechorionated embryos were homogenized and boiled in SDS load buffer. Samples run on 10% SDS-PAGE gels were transferred to nitrocellulose and immunostained. To generate anti-C-DmWWOX antibody, we used a synthetic peptide coupled with KLH and the immune sera from rabbits was purified against the GSTDmWWOX fusion protein and used at 1 : 200. For anti-NDmWWOX, the N-terminal 86 amino acids were fused to GST, purified and cleaved with thrombin. Immune sera from rabbits were preadsorbed against fixed DmWWOX 1 mutant embryos before being used at 1 : 1000. An anti-Rabbit HRP secondary antibody was used at 1 : 3000 (Jackson Laboratories). Mouse monoclonal a-tubulin (Sigma) was used at 1 : 10 000 with an antimouse HRP secondary antibody (Jackson Laboratories) used at 1 : 2000 for larvae and 1 : 9000 for embryos. For whole-mount immunolocalization studies, dechorionated embryos were fixed in 4% formaldehyde and incubated with either anti-N-DmWWOX (1 : 100) or anti-N-hWWOX (1 : 100). To generate an anti-NhWWOX antibody, the N-terminal 101 amino acids were fused to GST and immune sera from rabbits were purified against GSThWWOX. A biotinylated anti-rabbit secondary antibody (Jackson Laboratories) was used at 1 : 400 and a tertiary Strepavidin-Alexa 488 (Molecular Probes) was used at 1 : 200. DNA was visualized with Hoechst 33258 (10 mg/ml, Sigma). Wild-type (w 1118 ), hs-gal4, da-GAL4 and en-GAL4 stocks were obtained from Bloomington Drosophila Stock Center (Indiana University, Bloomington, IN, USA). cDNA clones of DmWWOX (LD03827) were obtained from Berkeley Drosophila Gene Project and human WWOX cDNA was isolated by RT-PCR from human RNA. These cDNA clones were amplified by PCR and cloned into pUAST (Brand and Perrimon, 1993) . Transgenic lines of UAS-DmWWOX and UAShWWOX were generated by standard transformation procedures (Chang et al., 2001) , although the significance of this interaction has been challenged (Aqeilan et al., 2004c; Ludes-Meyers et al., 2004) . Mutations generated in the Drosophila orthologue of p53, Dmp53, also resulted in viable adult flies with no obvious phenotype (Lee et al., 2003; Sogame et al., 2003) . However, both reports of Dmp53 mutant animals showed an increased sensitivity to ionizing radiation. Given this radiation sensitivity and the possible functional association between WWOX and p53 (Chang et al., 2001) , we assessed the effect of ionizing radiation on the survival of DmWWOX 1 mutants. Third instar wandering larvae were treated to varying doses of gamma irradiation and assayed for their survival to adulthood. DmWWOX 1 mutants were more sensitive than wild type, with a decrease in survival following irradiation in a dose-dependent manner (Figure 3a) . A significant amount of variation in the percentage survival was observed between experiments as evident by the large standard deviation at the different dosages. A similar level of variation in survival has previously been reported for both wild-type and Dmp53 mutants following irradiation (Sogame et al., 2003) .
The protective role of WWOX in Drosophila was confirmed by functional rescue of the radiation sensitivity of DmWWOX 1 mutants. A high level of ubiquitous expression of DmWWOX was observed throughout development in flies carrying both da-GAL4 and UAS-DmWWOX constructs (Figure 2b, lane 3,  da>DmWWOX) . A marked increase in the percentage survival to adulthood following irradiation was observed in DmWWOX 1 mutants carrying these constructs Figure 3 Radiation sensitivity of DmWWOX 1 mutants. (a) Percentage survival of DmWWOX 1 mutant flies to adulthood following irradiation was reduced compared to wild-type in a dosedependent manner. Under the experimental conditions used, 50% lethality (LD 50 ) for DmWWOX 1 mutants was approx. 15 Gy compared to an LD 50 of approx. 25 Gy for wild type. Varying numbers of larvae were tested at each dose (n ¼ 1000 for 0 Gy, n ¼ 300 for 10 Gy, n ¼ 150 for 15 Gy, n ¼ 3725 for 20 Gy, n ¼ 800 for 25 Gy and n ¼ 400 for 30 Gy) and error bars represent s.d. between separate experiments. Mitotic cells of wild-type (b) and DmWWOX 1 mutant (c) wing discs in the absence of irradiation visualized by anti-PH3 staining. Cell cycle arrest is observed 1.5 h after irradiation at 25 Gy in both wild-type (d) and DmWWOX 1 mutant (e) wing discs by the absence of mitotic cells. At 5.5 h after irradiation at 25 Gy, cells have re-entered the cell cycle in both wildtype (f) and DmWWOX 1 mutant (g) wing discs. Acridine orange stains of wild-type (h) and DmWWOX 1 mutant (i) wing discs showed only a few dying cells in the absence of irradiation. A significant increase in the number of dying cells was observed 4.5 h after irradiation at 25 Gy in both wild-type (j) and DmWWOX 1 mutant (k) wing discs. For radiation sensitivity experiments, wandering third instar larvae were collected and exposed to varying doses of gamma-irradiation using a CIS Bio-international IBL 437C machine. The total number of flies eclosed was scored after 5-6 days at 251C. For staining of mitotic cells, wing discs were dissected and fixed in 4% formaldehyde in PBS, rabbit anti-PH3 (Upstate Biotechnology) was used at 1 : 300. Secondary antibody was anti-rabbit Alexa 488 (Molecular Probes) at 1 : 300. For acridine orange stains, wing discs were dissected in PBS and stained for 5 min in a drop of 1.6 Â 10 À6 M acridine orange in PBS. Discs were then rinsed and mounted in PBS and the resulting fluorescence analysed immediately (Table 1 , DmWWOX rescue). Again there was significant variation in the percentage survival between experiments; however, within each experiment there was a definite trend of decreased survival of DmWWOX 1 mutants compared to wild-type, and a significant increase in survival in those mutants carrying the rescue constructs. A similar level of rescue was observed following ectopic expression of human WWOX in DmWWOX 1 mutants (Table 2 , hWWOX rescue). Thus, the protective function of WWOX in response to ionizing radiation has been conserved through evolution.
In response to ionizing radiation, checkpoints signal a cell cycle arrest to allow time for repair of the damaged DNA, while increased levels of apoptosis act to remove any cells that are damaged beyond repair (Sogame et al., 2003; Jaklevic and Su, 2004) . We found no significant effect on either of these responses following irradiation of the DmWWOX 1 mutants. Staining for mitotic cells with antiphosphohistone H3 (PH3) in the absence of irradiation showed normal levels of dividing cells in both wild-type and DmWWOX 1 mutant wing discs (Figure 3b-c) . The absence of staining in both wild-type and DmWWOX 1 mutants 1.5 h after 25 Gy irradiation revealed a functional cell cycle arrest (Figure 3d-e) . In addition, some cells in both wild-type and DmWWOX 1 mutants had re-entered the cell cycle by 5.5 h after irradiation (Figure 3f-g ). Acridine orange stains revealed very low levels of dying cells in both wild-type and DmWWOX 1 mutant wing discs in the absence of irradiation (Figure 3h-i) . However, in response to 25 Gy irradiation, both wild-type and DmWWOX 1 mutants showed a marked increase in the number of dying cells (Figure 3j-k) . This is in contrast to Dmp53 mutants where it was reported that dying cells could no longer be detected by acridine orange following irradiation (Sogame et al., 2003) . Thus, DmWWOX does not appear to be an essential component of the Dmp53-dependent cell death response following irradiation in Drosophila. However, this does not rule out the possibility of an interaction between DmWWOX and Dmp53 with a role in apoptosis or other stress response pathway(s). We have determined that the radiation sensitivity of DmWWOX 1 mutants is probably not due to a defect in cell cycle arrest or apoptosis. It will be of interest to determine whether the oxidoreductase activity of DmWWOX contributes to the observed protection after ionizing radiation, as has previously been shown for NQO1 (Nioi and Hayes, 2004) .
In vitro functional assays to date have shown a role for WWOX in various cellular processes. However, the relative significance of these findings in vivo is yet to be determined. This is the first report of a knockout of the WWOX gene allowing the normal biological function to be assessed. We found that either Drosophila or human WWOX act in a protective manner against the effects of ionizing radiation in Drosophila. This function is consistent with a role for common fragile site-associated genes in cancer cell biology since loss of function WWOX mutations could lead to a subsequent increase in cellular damage.
The function of WWOX in Drosophila may differ from mouse and human in some minor details, but we anticipate the major biological functions to be conserved as evident by the high level of amino-acid conservation and distinct phylogenetic relationship of WWOX proteins from other oxidoreductases. The FHIT gene spanning the FRA3B common fragile site has also been shown to play a protective role against carcinogeninduced neoplasia (Zanesi et al., 2001) . The finding that the two most sensitive human chromosomal fragile sites are both spanned by genes that play protective roles against environmental challenges could be merely coincidence. However, it is more likely that there is a functional relationship of some sort between these fragile sites and their respective genes resulting in a contribution to cancer cell biology. This is further supported by other striking similarities between the WWOX and FHIT genes. They are both extremely large (>1 Mb in mouse and human), they both are sites of DNA instability in human cancers and their association with fragile sites has been conserved in mouse (Glover et al., 1998; Krummel et al., 2002) . These features are also shared by the Parkin, gene which maps to FRA6E (Cesari et al., 2003; Denison et al., 2003; Picchio et al., 2004; Wang et al., 2004) and the ionotropic glutamate receptor delta 2 (GRID2) gene, which maps to FRA4F (Bluteau et al., 2002; Rozier et al., 2004) . These properties appear to have been acquired quite independently during evolution as the genes themselves bear no DNA sequence similarity nor are their encoded proteins members of the same protein superfamily. Together, these data strongly support the proposal that common chromosomal fragile sites and the genes in their immediate vicinity constitute part of a protective mechanism that is activated in response to environmental challenges.
